WO2003086290A3 - Electroprocessing of materials useful in drug delivery and cell encapsulation - Google Patents
Electroprocessing of materials useful in drug delivery and cell encapsulation Download PDFInfo
- Publication number
- WO2003086290A3 WO2003086290A3 PCT/US2003/010806 US0310806W WO03086290A3 WO 2003086290 A3 WO2003086290 A3 WO 2003086290A3 US 0310806 W US0310806 W US 0310806W WO 03086290 A3 WO03086290 A3 WO 03086290A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- drug delivery
- electroprocessing
- materials useful
- cell encapsulation
- substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
- D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003223513A AU2003223513A1 (en) | 2002-04-05 | 2003-04-07 | Electroprocessing of materials useful in drug delivery and cell encapsulation |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37057202P | 2002-04-05 | 2002-04-05 | |
US60/370,572 | 2002-04-05 | ||
US40050602P | 2002-08-02 | 2002-08-02 | |
US60/400,506 | 2002-08-02 | ||
US40221802P | 2002-08-08 | 2002-08-08 | |
US06/402,218 | 2002-08-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003086290A2 WO2003086290A2 (en) | 2003-10-23 |
WO2003086290A3 true WO2003086290A3 (en) | 2004-01-22 |
Family
ID=30773494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/010806 WO2003086290A2 (en) | 2002-04-05 | 2003-04-07 | Electroprocessing of materials useful in drug delivery and cell encapsulation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003223513A1 (en) |
WO (1) | WO2003086290A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1624953B1 (en) | 2003-04-23 | 2018-12-19 | The University of Akron | Sequestered reactive materials |
US7704740B2 (en) | 2003-11-05 | 2010-04-27 | Michigan State University | Nanofibrillar structure and applications including cell and tissue culture |
US20050109856A1 (en) * | 2003-11-25 | 2005-05-26 | Alexander James N.Iv | Method for preparing polymer electrosprays |
DE102005054941A1 (en) | 2005-11-17 | 2007-05-31 | Gelita Ag | nerve |
EP2061918A2 (en) * | 2006-09-06 | 2009-05-27 | Corning Incorporated | Nanofibers, nanofilms and methods of making/using thereof |
WO2010135300A2 (en) * | 2009-05-18 | 2010-11-25 | Cornell University | Biodegradable nanofibers and implementations thereof |
US20160243051A1 (en) * | 2013-10-24 | 2016-08-25 | The Curators Of The University Of Missouri | Mono disperse polymer nanoparticles, functionalized nanoparticles and controlled formation method |
CN106754367B (en) * | 2016-12-12 | 2019-06-21 | 吉林大学 | The method for carrying medicine cell climbing sheet is prepared by electrostatic spinning |
WO2019084209A1 (en) * | 2017-10-24 | 2019-05-02 | Embody Llc | Biopolymer scaffold implants and methods for their production |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4043331A (en) * | 1974-08-05 | 1977-08-23 | Imperial Chemical Industries Limited | Fibrillar product of electrostatically spun organic material |
WO1998003267A1 (en) * | 1996-07-23 | 1998-01-29 | Electrosols Ltd. | A dispensing device and method for forming material |
US6110484A (en) * | 1998-11-24 | 2000-08-29 | Cohesion Technologies, Inc. | Collagen-polymer matrices with differential biodegradability |
US6179872B1 (en) * | 1998-03-17 | 2001-01-30 | Tissue Engineering | Biopolymer matt for use in tissue repair and reconstruction |
US20010003148A1 (en) * | 1997-07-22 | 2001-06-07 | Coffee Ronald Alan | Dispensing device and method for forming material |
US6252129B1 (en) * | 1996-07-23 | 2001-06-26 | Electrosols, Ltd. | Dispensing device and method for forming material |
-
2003
- 2003-04-07 AU AU2003223513A patent/AU2003223513A1/en not_active Abandoned
- 2003-04-07 WO PCT/US2003/010806 patent/WO2003086290A2/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4043331A (en) * | 1974-08-05 | 1977-08-23 | Imperial Chemical Industries Limited | Fibrillar product of electrostatically spun organic material |
WO1998003267A1 (en) * | 1996-07-23 | 1998-01-29 | Electrosols Ltd. | A dispensing device and method for forming material |
US6252129B1 (en) * | 1996-07-23 | 2001-06-26 | Electrosols, Ltd. | Dispensing device and method for forming material |
US20010003148A1 (en) * | 1997-07-22 | 2001-06-07 | Coffee Ronald Alan | Dispensing device and method for forming material |
US6179872B1 (en) * | 1998-03-17 | 2001-01-30 | Tissue Engineering | Biopolymer matt for use in tissue repair and reconstruction |
US6110484A (en) * | 1998-11-24 | 2000-08-29 | Cohesion Technologies, Inc. | Collagen-polymer matrices with differential biodegradability |
Also Published As
Publication number | Publication date |
---|---|
WO2003086290A2 (en) | 2003-10-23 |
AU2003223513A1 (en) | 2003-10-27 |
AU2003223513A8 (en) | 2003-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO962088D0 (en) | Preparation for in vivo production of therapeutic products | |
DE60023520D1 (en) | LIQUID HIGH VISIBLE SYSTEM WITH CONTROLLED RELEASE AND MEDICAL OR SURGICAL DEVICE | |
AP2002002552A0 (en) | Pharmaceutical compositions providing enhanced drug concentrations. | |
RS51764B (en) | Transdermal pharmaceutical composition | |
MY144897A (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
AU2003225125A1 (en) | Fragrance release | |
CO5700698A2 (en) | COMPOSITIONS AND METHODS FOR ORAL AND PERSONAL CARE | |
EA200701655A1 (en) | MATERIALS FOR DELIVERY OF DRUGS OBTAINED BY THE SOL-GEL METHOD | |
WO2007048645A3 (en) | Protection of oxidizable agents | |
ATE402002T1 (en) | ELECTROPROCESSED COLLAGEN | |
SI1730147T1 (en) | SUBSTITUTED 1,4,8-TRIAZASPIRO?á4,5?åDECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY | |
ATE353009T1 (en) | PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH SOFT GELATIN FORMULATIONS | |
EP1493754A4 (en) | Polysaccharide containing phosphorylcholine group and process for producing the same | |
BR0114839A (en) | composition, and method of releasing a substance or electroprocessed material at a desired location | |
WO2003086290A3 (en) | Electroprocessing of materials useful in drug delivery and cell encapsulation | |
TW200635616A (en) | Organic compounds | |
ATE271387T1 (en) | MEDICINAL PREPARATIONS CONTAINING VITAMIN D AND CALCIUM, THEIR PRODUCTION AND THERAPEUTIC USE | |
WO2006041843A3 (en) | Pharmaceutical dosage form comprising meloxicam | |
ATE435864T1 (en) | SUBSTITUTED 5,6,7,8-TETRAHYDRO-IMIDAZOÄ1,2-AUPYRIDINE-2-YLAMIN COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICINAL PRODUCTS | |
WO2002089832A3 (en) | Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. | |
SG160201A1 (en) | Electroprocessing in drug delivery and cell encapsulation | |
ATE256134T1 (en) | SULFATED PHOSPHATIDYLINOSITOLS, THEIR PRODUCTION AND USE | |
KR100832359B1 (en) | Yellow mud pack and method for producing thereof | |
BR0109525A (en) | Composition, use of a composition, tablets or capsules, and method of preparing a solution or suspension | |
DE60023307D1 (en) | PHENANTHROLIN-7-ONDERIVATE AND ITS THERAPEUTIC USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |